SARS-CoV-2-IN-39

CAS No. 2882823-03-0

SARS-CoV-2-IN-39( —— )

Catalog No. M36928 CAS No. 2882823-03-0

SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 73 Get Quote
5MG 113 Get Quote
10MG 166 Get Quote
25MG 271 Get Quote
50MG 408 Get Quote
100MG 588 Get Quote
500MG 1215 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SARS-CoV-2-IN-39
  • Note
    Research use only, not for human use.
  • Brief Description
    SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1.
  • Description
    SARS-CoV-2-IN-39 (compound 21) is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 against SARS-CoV-2 by inhibiting of SKP2 protein and stabilizing BECN1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Antiviral
  • Recptor
    SARS-CoV | Antiviral
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2882823-03-0
  • Formula Weight
    349.66
  • Molecular Formula
    C14H8ClF4NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NC1=CC=C(OC(F)(F)F)C=C1)(=O)C2=C(O)C=C(F)C(Cl)=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rui Li, et al. Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2. Eur J Med Chem. 2023 May 5;253:115320. ?
molnova catalog
related products
  • YM-53403

    YM-53403 is an antiviral activity that effectively inhibits the replication of RSV strains belonging to subgroup A and subgroup B. It can be used to treat respiratory syncytial virus infections.

  • cis-Vaccenic acid

    cis-Vaccenic acid (Asclepic acid) is the antiviral extract from Rhodopseudomonas capsulate and the predominant active component of Rhodopseudomonas capsulate. cis-Vaccenic acid acts a potential fetal hemoglobin inducer.

  • DC 07090

    DC 07090 is a human enterovirus 71 3C protease inhibitor with antiviral activity for the study of nucleic acid virus infections.